NCT01626404已完成不适用
Screening for Advanced Heart Failure Treatment (SEE-HF)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 99
- 试验地点
- 7
- 主要终点
- Proportion of patients
研究概览
简要总结
Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who are candidates for advanced heart failure treatment and obtain insights into patient and physician decisions regarding referral for advanced heart failure therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •CRT and or ICD device in place.
- •NYHA class III - IV heart failure
- •EF </= 40%
- •Patient is an out-patient
- •Patient is on optimal medical management as tolerated and as defined by primary care physician.
- •Patient has signed an informed consent for data collection.
排除标准
- •Age <18 years or >80 years
- •CRT device that has been implanted < 3 months prior to enrollment
- •Coronary revascularization within 3 months prior to enrollment
- •Patient only has ICD but has CRT planned
- •Non-cardiac disease resulting in life expectancy < 2 yrs
- •Patient is hospitalized or will be hospitalized at this time
- •Known diagnosis of dementia
- •Patient is currently on dialysis
- •Oxygen dependent lung disease
- •Previously or currently treated with LVAD or heart transplantation
结局指标
主要结局
Proportion of patients
时间窗: 12 months
Proportion of heart failure patients followed in outpatient clinic that are NYHA III-IV with LVEF \</= 40% and a CRT and/or ICD who have an indication without contraindication for heart transplantationi and/or DT LVAD.
次要结局
- Patient's reasons(12 months)
- Actual and predicted 12 month survival(12 months)
- Reasons for non-referral(12 months)
- Simple clinical parameters for referral(12 months)
研究者
研究点 (7)
Loading locations...
相似试验
已完成
1 期
A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance ImmediatelyChildrenHeart FailureNCT05086952Bayer36
已完成
2 期
Biomarker Guided Therapies in Stage A/B Heart FailureHypertensionDiabetesCardiovascular DiseaseNCT02230891VA Office of Research and Development58
已完成
4 期
A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)Chronic Heart Failure With Reduced Ejection FractionWorsening Heart FailureNCT05658458Bayer205
已完成
3 期
Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant PatientsHeart TransplantationNCT00169936Mayo Clinic6
招募中
不适用
Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart FailureHeart FailureNCT04554277University Hospital, Montpellier710